Treatment of viral diseases of the cornea and external eye

Progress in Retinal and Eye Research

Volumn 19, Issue 1, 2000, Pages 69-85

  Kaufman, Herbert E ^a  

^a LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIDOFOVIR; CORTICOSTEROID; FAMCICLOVIR; PENCICLOVIR; TETRACYCLINE DERIVATIVE; TRIFLURIDINE; VALACICLOVIR;

BLEPHARITIS; ENTEROVIRUS INFECTION; EPSTEIN BARR VIRUS; EYE DISEASE; HERPES SIMPLEX KERATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; IRITIS; KERATITIS; MEASLES VIRUS; MUMPS VIRUS; PRIORITY JOURNAL; REVIEW; RUBELLA VIRUS; TRACHOMA; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ADENOVIRUS INFECTIONS, HUMAN; ANIMALS; ANTIVIRAL AGENTS; CLINICAL TRIALS; CORNEAL DISEASES; EYE INFECTIONS, VIRAL; HERPES ZOSTER OPHTHALMICUS; HUMANS; KERATITIS, HERPETIC; TRACHOMA;

EID: 0033990304     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-9462(99)00004-X     Document Type: Review

References (45)

1. Barney N.P., Foster C.S. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea. 13:1994;232-236.
2. Baringer J.R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N. Engl. J. Med. 288:1973;648-650.
3. Barron B.A., Gee L., Hauck W.W., Kurinij N., Dawson C.R., Jones D.B., Wilhelmus K.R., Kaufman H.E., Sugar J., Hyndiuk R.A., Laibson P.R., Stulting R.D., Asbell P.A. For the Herpetic Eye Disease Study Group. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 101:1994;1871-1882.
4. Carmine A.A., Brogden R.N., Heel R.C., Speight T.M., Avery G.S. Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections. Drugs. 23:1982;329-353.
5. Centifanto-Fitzgerald Y.M., Varnell E.D., Kaufman H.E. Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains. Infect. Immun. 35:1982;1125-1132.
6. Chavez-de la Paz E., Fernando Arevalo J., Kirsch L.S., Munguia D., Rahhal F.M., De Clercq E., Freeman W.R. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. Ophthalmology. 104:1997;539-544.
7. Cremer K.J., Mackett M., Wohlenberg C., Notkins A.L., Moss B. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science. 228:1985;737-740.
8. de Oliveira C.B.R., Stevenson D., LaBree L., McDonnell P.J., Trousdale M.D. Evaluation of cidofovir (HPMPC, GC-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res. 31:1996;165-172.
9. Degreef, H. and the Famciclovir Herpes Zoster Clinical Study Group (1994) Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int. J. Antimicrob. Agents 4, 241-246.
10. Elion G.B., Furman P.A., Fyfe J.A., de Miranda P., Beauchamp L., Schaeffer H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. USA. 74:1977;5716-5720.
11. Gebhardt B.M., Kaufman H.E. Propranolol suppresses reactivation of herpesvirus. Antiviral Res. 27:1995;255-261.
12. Gebhardt, B. M., Kaufman, H. E. and Hill, J. M. (0000) Effect of acyclovir on thermal stress-induced viral reactivation. Antiviral Res., submitted.
13. 2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in mice. Antiviral Res. 30:1996;87-94.
14. Ghiasi H., Bahri S., Nesburn A.B., Wechsler S.L. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest. Ophthalmol. Vis. Sci. 36:1995;1352-1360.
15. Gordon Y.J., Romanowski E., Araullo-Cruz T., De Clercq E. Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model. Cornea. 11:1992;529-533.
16. Gordon Y.J., Romanowski E.G., Araullo-Cruz T. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model. Cornea. 13:1994;516-520.
17. Herpetic Eye Disease Study Group (1996) A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch. Ophthalmol. 114, 1065-1072.
18. Herpetic Eye Disease Study Group (1997) A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The epithelial keratitis trial. Arch. Ophthalmol. 115, 703-712.
19. Herpetic Eye Disease Study Group (1998) Acyclovir for the prevention of recurrent herpes simplex virus eye disease. New Engl. J. Med. 339, 300-306.
20. Hovding G. A comparison between acyclovir and trifluorothymidine ophthalmic ointment in the treatment of epithelial dendritic keratitis: a double blind, randomized parallel group trial. Acta Ophthalmol (Copenh). 67:1989;51-54.
21. Hung S.O., Patterson A., Rees P.J. Pharmacokinetics of oral acyclovir (Zovirax) in the eye. Br. J. Ophthalmol. 68:1984;192-195.
22. Kaufman H.E. Clinical cure of herpes simplex keratitis by 5-iodo-2′-deoxyuridine. Proc. Soc. Exp. Biol. Med. 109:1962;251-252.
23. Kaufman H.E. Treatment of deep herpetic keratitis with IDU and corticosteroids. E.E.N.T. Digest. 25:1963;37-40.
24. Kaufman H.E. Epithelial erosion syndrome: metaherpetic keratitis. Am. J. Ophthalmol. 57:1964;983-987.
25. Kaufman H.E., Heidelberger C. Therapeutic anti-viral action of 5-trifluoromethyl-2′-deoxyuridine. Science. 145:1964;585-586.
26. Kaufman H.E., Brown D.C., Ellison E.D. Herpes virus in the lacrimal gland, conjunctiva and cornea of man - a chronic infection. Am. J. Ophthalmol. 65:1968;32-35.
27. Kaufman H.E., Martola E.-L., Dohlman C.H. Herpes simplex treatment with IDU and corticosteroids. Arch. Ophthalmol. 69:1963;468-472.
28. Kaufman H.E., Varnell E.D., Thompson H.W. Comparison of trifluridine, cidofovir, and penciclovir in the treatment of herpetic keratitis in the rabbit. Arch. Ophthalmol. 116:1998;777-780.
29. Kaufman H.E., Varnell E.D., Cheng Y.C., Bobek M., Thompson H.W., Dutschman G.E. Suppression of ocular herpes recurrences by a thymidine kinase inhibitor in squirrel monkeys. Antiviral Res. 16:1991;227-232.
30. 2-phenylguanine (HBPG), a thymidine kinase inhibitor, on clinical recurrences of ocular herpetic keratitis in squirrel monkeys. Antiviral Res. 33:1996;65-72.
31. La Lau C., Oosterhuis J.A., Versteeg G., van Rij G., Renardel de Lavalette J.G., Craandijk A., Lamers W.R., Mierlobensteyn T. Aciclovir and trifluorothymidine in herpetic keratitis: preliminary report of a multicentered trial. Doc. Ophthalmol. 50:1981;287-290.
32. Maudgal P.C., De Clercq E. (S)-1-(3-hydroxy-2-phosphonylmethyoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis. Invest. Ophthalmol. Vis. Sci. 32:1991;1816-1820.
33. Moyes A.L., Sugar A., Musch D.C., Barnes R.D. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch. Ophthalmol. 112:1994;601-607.
34. National Eye Institute. Vision Research: A National Plan. U.S. Department of Health and Human Services, United States Public Health Services, Washington, DC, 1993. NIH Publication No. 93-3186, p. 138.
35. Ratnam S., West R., Gadag V., Burris J. Measles immunization strategy: measles antibody response following MMR II vaccination of children at one year of age. Can. J. Public Health. 87:1996;97-100.
36. Romanowski E.G., Bartels S.P., Gordon Y.J. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. Invest. Ophthalmol. Vis. Sci. 40:1999;378-384.
37. Shuster J.J., Kaufman H.E., Nesburn A.B. Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease. Am. J. Ophthalmol. 91:1981;328-331.
38. Stansfield S.K., de la Pena W., Koenig S., Espaillat Cabral A., Kaufman H., Hatch M.H., Hierholzer J., Schonberger L.B. J. Infect. Dis. 149:1984;822-823.
39. Stevens J.G., Haarr L., Porter D.D., Cook M.L., Wagner E.K. Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. J. Infect. Dis. 158:1988;117-123.
40. Taskintuna I., Rahhal F.M., Fernando Arevalo J., Munguia D., Banker A.S., De Clercq E., Freeman W.R. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 104:1997;1049-1057.
41. Taskintuna I., Rahhal F.M., Rao N.A., Wiley C.A., Mueller A.J., Banker A.S., De Clercq E., Fernando Arevalo J., Freeman W.R. Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome. Ophthalmology. 104:1997;1827-1837.
42. Varnell, E.D., Centifanto-Fitzgerald, Y.M. and Kaufman H.E. (1982) Herpesvirus infection and its effect on virulent superinfection, ganglionic colonization, and shedding. In: Herpesvirus: Clinical, Pharmacological and Basic Aspects. H. Shiota, Y-C. Cheng, W.H. Prusoff, eds. Excerpta Medica, Amsterdam, 1982, pp. 21-24.
43. Warren K.G., Brown S.M., Wroblewska Z., Gilden D., Koprowski H., Subak-Sharpe J. Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N. Engl. J. Med. 298:1978;1068-1069.
44. Wellings P.C., Awdry P.N., Bors F.H., Jones B.R., Brown D.C., Kaufman H.E. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am. J. Ophthalmol. 73:1972;932-942.
45. Wilhelmus K.R., Gee L., Hauck W.W., Kurinij N., Dawson C.R., Jones D.B., Barron B.A., Kaufman H.E., Sugar J., Hyndiuk R.A., Laibson P.R., Stulting R.D., Asbell P.A. For the Herpetic Eye Disease Study Group. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 101:1994;1883-1896.